亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Progression of mild cognitive impairment to dementia in German specialist practices

痴呆 德国的 认知障碍 认知 医学 心理学 老年学 精神科 疾病 历史 内科学 考古
作者
Jens Bohlken,Louis Jacob,Karel Kostev
出处
期刊:Dementia [SAGE]
卷期号:18 (1): 380-390 被引量:23
标识
DOI:10.1177/1471301216673919
摘要

The goal of this study was to estimate the rate of the progression of mild cognitive impairment to dementia and identify the potential risk factors in German specialist practices from 2005 to 2015. This study included 4633 patients aged 40 years and over from 203 neuropsychiatric practices, who were initially diagnosed with mild cognitive impairment between 2005 and 2013. The primary outcome was diagnosis of all-cause dementia recorded in the database until the end of the five-year follow-up period. Cox regression models were used to examine mild cognitive impairment progression to dementia when adjusted for confounders (age, sex, and health-insurance type). The mean age was 68.9 years and 46.6% were men. After the five-year follow-up period, 38.1% of women and 30.4% of men had been diagnosed with dementia ( p < 0.001). The share of subjects with dementia increased with age, rising from 6.6% in the age group of ≤ 60 years to 64.7% in the age group of > 80 years ( p < 0.001). Men were at a lower risk of being diagnosed with dementia than women (hazard ratio = 0.86). Patients in the age groups 61-70, 71-80, and > 80 years also had a higher risk of developing this psychiatric disorder, with hazard ratios ranging from 3.50 to 11.71. Finally, mild cognitive impairment was less likely to progress to dementia in people with private health-insurance coverage than in people with public health-insurance coverage (hazard ratio = 0.69). Around one in three patients developed dementia in the five years following mild cognitive impairment diagnosis. Sex, age, and type of health insurance were associated with this risk.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
haha发布了新的文献求助10
7秒前
8秒前
生动的箴发布了新的文献求助10
13秒前
科研通AI2S应助科研通管家采纳,获得10
17秒前
31秒前
老石完成签到 ,获得积分10
33秒前
刻苦小凝发布了新的文献求助10
37秒前
37秒前
宓函发布了新的文献求助10
41秒前
波里舞完成签到 ,获得积分10
52秒前
赘婿应助蒲亚东采纳,获得10
1分钟前
1分钟前
蒲亚东发布了新的文献求助10
1分钟前
英俊的铭应助nana2hao采纳,获得10
1分钟前
1分钟前
nana2hao发布了新的文献求助10
1分钟前
LiuJiateng应助抹茶芝麻糊糊采纳,获得10
1分钟前
1分钟前
1分钟前
2分钟前
彭于晏应助科研通管家采纳,获得10
2分钟前
英俊的铭应助科研通管家采纳,获得10
2分钟前
科研通AI6.2应助刻苦小凝采纳,获得10
2分钟前
爱学习的小李完成签到 ,获得积分10
2分钟前
早日毕业脱离苦海完成签到 ,获得积分10
2分钟前
3分钟前
科研通AI6.2应助星落枝头采纳,获得10
3分钟前
3分钟前
周炎发布了新的文献求助30
3分钟前
3分钟前
星落枝头发布了新的文献求助10
3分钟前
彭于晏应助蒲亚东采纳,获得10
3分钟前
大个应助周炎采纳,获得10
3分钟前
3分钟前
3分钟前
蒲亚东发布了新的文献求助10
3分钟前
4分钟前
科研通AI6.3应助等待戈多采纳,获得10
4分钟前
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Weaponeering, Fourth Edition – Two Volume SET 1000
First commercial application of ELCRES™ HTV150A film in Nichicon capacitors for AC-DC inverters: SABIC at PCIM Europe 1000
Handbook of pharmaceutical excipients, Ninth edition 800
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5996989
求助须知:如何正确求助?哪些是违规求助? 7472866
关于积分的说明 16081597
捐赠科研通 5140062
什么是DOI,文献DOI怎么找? 2756132
邀请新用户注册赠送积分活动 1730598
关于科研通互助平台的介绍 1629796